Special Issue "Marine Shellfish Toxins"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 October 2013)

Special Issue Editor

Guest Editor
Dr. Alison Robertson
Marine Toxicology & Chemistry, Department of Marine Sciences, University of South Alabama, Mobile, AL 36688, USA
Website: http://www.usouthal.edu/marinesciences/index.html
E-Mail: arobertson@disl.org
Interests: marine and freshwater toxin chemistry; biochemical pathways; metabolism; biomarkers of exposure; and method development for detection of chemical hazards in seafood

Special Issue Information

Dear Colleagues,

Shellfish toxins pose a significant public health concern worldwide. These toxins are potent bioactive metabolites produced by a variety of dinoflagellate, diatom, and cyanobacterial species in marine and freshwater ecosystems.  Within each major class, these toxins include a vast array of congeners, differing greatly in terms of structure, pharmacological action, and toxicity. This combined special issue for Marine Drugs and Toxins is dedicated to recent advances in marine and freshwater shellfish toxin research. We encourage shellfish toxin research that reports on: 1) the discovery of novel shellfish toxins, metabolites and biochemical pathways relevant to human health, 2) the elucidation of biochemical or molecular targets for toxin detection, 3) research that enhances our understanding and linkage of ecological and functional roles of shellfish toxins, and 4) evaluation of new and emerging human health hazards on a regional and global scale including the evaluation of trophic pathways and toxicology.

I am honored to serve as a guest editor for this special issue and would encourage all scientists to submit their latest findings in an effort to enhance our collective knowledge and communication of marine and freshwater shellfish toxin research.

Dr. Alison Robertson
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • shellfish toxins
  • harmful algal blooms
  • dinoflagellates
  • diatoms
  • cyanobacteria
  • cyanotoxins
  • bioaccumulation
  • biomolecular pathways
  • toxicology
  • trophic transfer
  • chemical ecology

Published Papers (7 papers)

Mar. Drugs 2014, 12(1), 394-461; doi:10.3390/md12010394
Received: 11 November 2013; in revised form: 29 November 2013 / Accepted: 31 December 2013 / Published: 20 January 2014
Show/Hide Abstract | Download PDF Full-text (1647 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(12), 4799-4814; doi:10.3390/md11124799
Received: 27 September 2013; in revised form: 31 October 2013 / Accepted: 6 November 2013 / Published: 2 December 2013
Show/Hide Abstract | Download PDF Full-text (612 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Mar. Drugs 2013, 11(12), 4724-4740; doi:10.3390/md11124724
Received: 3 September 2013; in revised form: 6 October 2013 / Accepted: 17 October 2013 / Published: 28 November 2013
Show/Hide Abstract | Download PDF Full-text (861 KB) | View HTML Full-text | Download XML Full-text
abstract graphic

Mar. Drugs 2013, 11(12), 4698-4723; doi:10.3390/md11124698
Received: 12 September 2013; in revised form: 10 November 2013 / Accepted: 12 November 2013 / Published: 28 November 2013
Show/Hide Abstract | Download PDF Full-text (959 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(9), 3381-3409; doi:10.3390/md11093381
Received: 21 June 2013; in revised form: 15 July 2013 / Accepted: 15 July 2013 / Published: 6 September 2013
Show/Hide Abstract | Download PDF Full-text (1320 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(9), 3350-3371; doi:10.3390/md11093350
Received: 5 June 2013; in revised form: 18 July 2013 / Accepted: 7 August 2013 / Published: 2 September 2013
Show/Hide Abstract | Download PDF Full-text (731 KB) | View HTML Full-text | Download XML Full-text |  Supplementary Files

Mar. Drugs 2013, 11(8), 2814-2828; doi:10.3390/md11082814
Received: 22 May 2013; in revised form: 4 July 2013 / Accepted: 8 July 2013 / Published: 8 August 2013
Show/Hide Abstract | Download PDF Full-text (598 KB) | View HTML Full-text | Download XML Full-text

Last update: 23 September 2013

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert